Development and validation of the scale for symptom clusters in patients with myasthenia gravis

Abstract Background Patients with myasthenia gravis(MG)often experience multiple symptoms concurrently, which can have an adverse effect on their quality of life(QOL). However, a specific, systemic and reliable scale for symptom clusters in MG is lacking. Aims To develop reliable assessment scale fo...

Full description

Bibliographic Details
Main Authors: Fan Shen, Lu-Hong Hu, Hai-Shan Huang, Ling Li
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Neurology
Subjects:
Online Access:https://doi.org/10.1186/s12883-023-03240-4
_version_ 1797822787404955648
author Fan Shen
Lu-Hong Hu
Hai-Shan Huang
Ling Li
author_facet Fan Shen
Lu-Hong Hu
Hai-Shan Huang
Ling Li
author_sort Fan Shen
collection DOAJ
description Abstract Background Patients with myasthenia gravis(MG)often experience multiple symptoms concurrently, which can have an adverse effect on their quality of life(QOL). However, a specific, systemic and reliable scale for symptom clusters in MG is lacking. Aims To develop reliable assessment scale for symptom clusters in patients with MG. Design A cross-sectional descriptive study. Methods Based on the unpleasant symptom theory(TOUS), the first draft of the scale was developed through review literature, qualitative interview, and Delphi expert correspondence, the items of the scale were presented and adjusted through cognitive interviews with 12 patients. To conveniently assess the validity and reliability of the scale, a cross-sectional survey was conducted in 283 patients with MG who were recruited from Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, from June to September 2021. Results The final symptom cluster scale for patients with MG consisted of 19 items(MGSC-19), with a content validity index ranging from 0.828 to 1.000 for each item and the content validity index was 0.980. Four common variables (ocular muscle weakness, general muscular weakness, treatment-related side effects, and psychiatric problems) were identified by exploratory factor analysis, which explained 70.187% of the total variance. The correlation coefficients between the scale dimension and the overall score ranged from 0.395 to 0.769 (all P < 0.01), while the correlation coefficients between dimensions varied from 0.324 to 0.510 (all P < 0.01). The Cronbach’s alpha, retest reliability, and half reliability were 0.932, 0.845, and 0.837, respectively. Conclusion The validity and reliability of MGSC-19 were generally good. This scale can be employed to identify the symptom clusters to help healthcare givers develop individualized symptom management measures for patients with MG.
first_indexed 2024-03-13T10:14:20Z
format Article
id doaj.art-247759f28ede473eaf8a324268f9608f
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-03-13T10:14:20Z
publishDate 2023-05-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-247759f28ede473eaf8a324268f9608f2023-05-21T11:19:28ZengBMCBMC Neurology1471-23772023-05-012311810.1186/s12883-023-03240-4Development and validation of the scale for symptom clusters in patients with myasthenia gravisFan Shen0Lu-Hong Hu1Hai-Shan Huang2Ling Li3Nursing Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNursing Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNursing Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyNursing Department, Tongji Hospital, Tongji Medical College, Huazhong University of Science and TechnologyAbstract Background Patients with myasthenia gravis(MG)often experience multiple symptoms concurrently, which can have an adverse effect on their quality of life(QOL). However, a specific, systemic and reliable scale for symptom clusters in MG is lacking. Aims To develop reliable assessment scale for symptom clusters in patients with MG. Design A cross-sectional descriptive study. Methods Based on the unpleasant symptom theory(TOUS), the first draft of the scale was developed through review literature, qualitative interview, and Delphi expert correspondence, the items of the scale were presented and adjusted through cognitive interviews with 12 patients. To conveniently assess the validity and reliability of the scale, a cross-sectional survey was conducted in 283 patients with MG who were recruited from Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, from June to September 2021. Results The final symptom cluster scale for patients with MG consisted of 19 items(MGSC-19), with a content validity index ranging from 0.828 to 1.000 for each item and the content validity index was 0.980. Four common variables (ocular muscle weakness, general muscular weakness, treatment-related side effects, and psychiatric problems) were identified by exploratory factor analysis, which explained 70.187% of the total variance. The correlation coefficients between the scale dimension and the overall score ranged from 0.395 to 0.769 (all P < 0.01), while the correlation coefficients between dimensions varied from 0.324 to 0.510 (all P < 0.01). The Cronbach’s alpha, retest reliability, and half reliability were 0.932, 0.845, and 0.837, respectively. Conclusion The validity and reliability of MGSC-19 were generally good. This scale can be employed to identify the symptom clusters to help healthcare givers develop individualized symptom management measures for patients with MG.https://doi.org/10.1186/s12883-023-03240-4Myasthenia gravisSymptom clustersScaleUnpleasant symptom theoryReliabilityValidity
spellingShingle Fan Shen
Lu-Hong Hu
Hai-Shan Huang
Ling Li
Development and validation of the scale for symptom clusters in patients with myasthenia gravis
BMC Neurology
Myasthenia gravis
Symptom clusters
Scale
Unpleasant symptom theory
Reliability
Validity
title Development and validation of the scale for symptom clusters in patients with myasthenia gravis
title_full Development and validation of the scale for symptom clusters in patients with myasthenia gravis
title_fullStr Development and validation of the scale for symptom clusters in patients with myasthenia gravis
title_full_unstemmed Development and validation of the scale for symptom clusters in patients with myasthenia gravis
title_short Development and validation of the scale for symptom clusters in patients with myasthenia gravis
title_sort development and validation of the scale for symptom clusters in patients with myasthenia gravis
topic Myasthenia gravis
Symptom clusters
Scale
Unpleasant symptom theory
Reliability
Validity
url https://doi.org/10.1186/s12883-023-03240-4
work_keys_str_mv AT fanshen developmentandvalidationofthescaleforsymptomclustersinpatientswithmyastheniagravis
AT luhonghu developmentandvalidationofthescaleforsymptomclustersinpatientswithmyastheniagravis
AT haishanhuang developmentandvalidationofthescaleforsymptomclustersinpatientswithmyastheniagravis
AT lingli developmentandvalidationofthescaleforsymptomclustersinpatientswithmyastheniagravis